Home › Bipolar Disorder › Arkansas
Bipolar Disorder clinical trials in Arkansas
6 studies for Bipolar Disorder are looking for participants at sites in Arkansas.
Cities in Arkansas
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Pillar Clinical Research, LLC, Little Rock
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 25, 2026 · NCT06229210Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
- Pillar Clinical Research, LLC, Little Rock
RecruitingPhase 3
Ages 10 to 17 · All sexes · Updated Sep 25, 2026 · NCT06372964A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Bryant
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07105111A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
- Woodland International Research Group, Little Rock
- Woodland Research Northwest, Rogers
RecruitingPhase 3
Ages 18 to 74 · All sexes · Updated Sep 2, 2026 · NCT07172516A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
- Sanro Clinical Research Group /ID# 279462, Bryant
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Aug 14, 2026 · NCT06696755A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
- Pillar Clinical Research - Bentonville, Bentonville
- Pillar Clinical Research- Little Rock, Little Rock
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Jun 23, 2026 · NCT07140913From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.